The SIV Biosafety Level 3 (BL3) Core Laboratory will be directed by Dr. M. Christine Zink. The BL3 technical staff will be responsible for processing all samples from the infected and uninfected control macaques throughout the experiments described in this Program and will provide samples and reagents to all projects in the program. This core laboratory will fulfill the following Specific Aims: To provide expert support in the preparation of SIV and HIV stocks, and quantitation of virus stocks for all projects. To receive, process, aliquot and log into appropriate databases all samples from infected and uninfected macaques. To isolate lymphocytes from blood (and lymph nodes, spleen and brain at necropsy) of uninfected and infected macaques to quantitate and perform longitudinal characterization of the activation and effector state of CD4+/CD8 + and cells and to use these cells in experiments in Projects 1 and 3. To isolate monocytes from blood of uninfected and infected macaques for experimental studies in Projects 1-4. To isolate macrophages/microglia and astrocytes from the brains of all infected and uninfected macaques for analysis for Projects 1, 2 and 4. To aliquot and archive plasma and CSF samples for viral load and other assays. To prepare samples for Real Time PCR, extraction of RNA or DNA for Projects 1 and 2. To process, aliquot and archive blood cells and plasma, CSF and other tissues at necropsy of each macaque in the study as described in the specific projects. To establish primary cell cultures, and maintain cell lines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
1P01MH070306-01
Application #
6983302
Study Section
Special Emphasis Panel (ZMH1-BRB-P (08))
Project Start
2003-12-01
Project End
2008-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
1
Fiscal Year
2004
Total Cost
$185,592
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Beck, Sarah E; Queen, Suzanne E; Metcalf Pate, Kelly A et al. (2018) An SIV/macaque model targeted to study HIV-associated neurocognitive disorders. J Neurovirol 24:204-212
Croteau, Joshua D; Engle, Elizabeth L; Queen, Suzanne E et al. (2017) Marked Enteropathy in an Accelerated Macaque Model of AIDS. Am J Pathol 187:589-604
Gannon, Patrick J; Akay-Espinoza, Cagla; Yee, Alan C et al. (2017) HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via ?-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. Am J Pathol 187:91-109
Gama, Lucio; Abreu, Celina M; Shirk, Erin N et al. (2017) Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS 31:5-14
Williams, Dionna W; Engle, Elizabeth L; Shirk, Erin N et al. (2016) Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol 186:2068-2087
Saylor, Deanna; Dickens, Alex M; Sacktor, Ned et al. (2016) HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12:234-48
Mangus, Lisa M; Dorsey, Jamie L; Weinberg, Rachel L et al. (2016) Tracking Epidermal Nerve Fiber Changes in Asian Macaques: Tools and Techniques for Quantitative Assessment. Toxicol Pathol 44:904-12
Avalos, Claudia R; Price, Sarah L; Forsyth, Ellen R et al. (2016) Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques. J Virol 90:5643-5656
Beck, Sarah E; Queen, Suzanne E; Viscidi, Raphael et al. (2016) Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control. J Neurovirol 22:498-507
Hosseini, Iraj; Gama, Lucio; Mac Gabhann, Feilim (2015) Multiplexed Component Analysis to Identify Genes Contributing to the Immune Response during Acute SIV Infection. PLoS One 10:e0126843

Showing the most recent 10 out of 80 publications